The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
D000276:Adjuvants, Immunologic / Q000592:standards / Q000627:therapeutic use*; D000818:Animals; D000942:Antigens, Bacterial / Q000008:administration & dosage; D001402:B-Lymphocytes / Q000276:immunology; D001500:BCG Vaccine; D002462:Cell Membrane / Q000276:immunology; D003352:Corynebacterium / Q000276:immunology; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D006462:Hemolytic Plaque Technique; D006801:Humans; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007939:Leukemia L1210 / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D051379:Mice; D009163:Mycobacterium bovis / Q000276:immunology; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology / Q000628:therapy; D011070:Poly I-C; D011119:Polynucleotides; D012075:Remission, Spontaneous; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D001500:BCG Vaccine; D011119:Polynucleotides; D011070:Poly I-C